Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001493152-25-001145
Filing Date
2025-01-07
Accepted
2025-01-07 11:14:55
Documents
2

Document Format Files

Seq Description Document Type Size
1 forms-3a.htm S-3/A 128482
2 ex23-1.htm EX-23.1 4088
  Complete submission text file 0001493152-25-001145.txt   133880
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-280244 | Film No.: 25513869
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)